4 analysts have expressed a variety of opinions on Amneal Pharmaceuticals (NASDAQ:AMRX) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 1 | 0 | 0 | 0 |
| Last 30D | 2 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 1 | 0 | 0 | 0 |
| 3M Ago | 1 | 0 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $7.81, along with a high estimate of $9.00 and a low estimate of $6.25. Marking an increase of 26.17%, the current average surpasses the previous average price target of $6.19.
Analyzing Analyst Ratings: A Detailed Breakdown
The analysis of recent analyst actions sheds...
Login or create a forever free account to read this news
Sign up/Log in